Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Gastroenterology
Published in: Indian Journal of Gastroenterology 2/2024

05-04-2024 | Acute Liver Failure | Narrative review

Acute kidney injury in acute liver failure: A narrative review

Authors: Brij Sharma, Anshul Bhateja, Rajesh Sharma, Ashish Chauhan, Vishal Bodh

Published in: Indian Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

Acute kidney injury (AKI) is a frequent complication of acute liver failure (ALF) and it worsens the already worse prognoses of ALF. ALF is an uncommon disease, with varying etiologies and varying definitions in different parts of the world. There is limited literature on the impact of AKI on the outcome of ALF with or without transplantation. The multifaceted etiology of AKI in ALF encompasses factors such as hemodynamic instability, systemic inflammation, sepsis and direct nephrotoxicity. Indications of renal replacement therapy (RRT) for AKI in ALF patients extend beyond the conventional criteria for dialysis and continuous renal replacement therapy (CRRT) may have a role in transplant-free survival or bridge to liver transplantation (LT). LT is a life-saving option for ALF, so despite somewhat lower survival rates of LT in ALF patients with AKI, LT is not usually deferred. In this review, we will discuss the guidelines’ recommended definition and classification of AKI in ALF, the impact of AKI in ALF, the pathophysiology of AKI and the role of CRRT and LT in ALF patients with AKI.
Literature
1.
Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023;118:1128–53.CrossRefPubMed
2.
Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure: update 2011. Hepatology. 2011;55:965–7.CrossRef
3.
Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver consensus statement on acute liver failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.CrossRefPubMedPubMedCentral
4.
Anand AC, Nandi B, Acharya SK, et al. INASL task-force on acute liver failure. Indian National Association for the Study of Liver consensus statement on acute liver failure (part-2) management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.
5.
Wendon J, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.CrossRefPubMed
6.
Tandon BN, Bernauau J, O’Grady J. Recommendations of the International Association for the Study of the Liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.
7.
O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.CrossRefPubMed
8.
9.
Feldman M, Friedman LS, Bandt LJ, et al. Acute liver failure, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th ed. In: O'Grady J, Bernal W, editors. Philadelphia: Elsevier; 2021. p. 1499–508.
10.
Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.
11.
Hadem J, Kielstein JT, Manns MP, et al. Outcomes of renal dysfunction in patients with acute liver failure. United Eur Gastroenterol J. 2019;7:388–96.
12.
Urrunaga NH, Magder LS, Weir MR, et al. Prevalence, severity, and impact of renal dysfunction in acute liver failure on the US liver transplant waiting list. Dig Dis Sci. 2016;61:309–16.
13.
Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448–55.CrossRefPubMed
14.
Kumar R, Shalimar, Bhatia V, et al. Anti-tuberculosis therapy induced acute liver failure: magnitude, profile, prognosis and predictors of outcome. Hepatology. 2010;51:1665–74.
15.
Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hep. 2003;10:224–31.CrossRef
16.
Coelho S, Fonseca JN, Gameiro J, Jorge S, Velosa J, Lopes JA. Transient and persistent acute kidney injury in acute liver failure. J Nephrol. 2019;32:289–96.
17.
Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.CrossRefPubMed
18.
Angeli P, Gines P, Wong F, et al. International club of ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531–7.
19.
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi. 2019;27:18–26.
20.
Escorsell A, Castellote J, Sa´nchez-Delgado J, et al. Management of acute liver failure: clinical guideline from the Catalan Society of Digestology. Gastroenterol Hepatol. 2019;42:51–64.CrossRefPubMed
21.
Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71:811–22.
22.
Leventhal TM, Liu KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis. 2015;22:376–81.
23.
Siniscalchi A, Dante A, Spedicato S, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transpl Proc. 2010;42:1197–9.
24.
25.
Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75.
26.
27.
Guevara M, Ginès P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998;28:416–22.CrossRefPubMed
28.
Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439–47.CrossRefPubMed
29.
Imoto K, Tanaka M, Goya T, et al. Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha. Medicine (Baltimore). 2023;102:e35931.
30.
Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed
31.
Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology. 1998;27:1227–32.CrossRefPubMed
32.
Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61:920–9.
33.
Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49–53.CrossRefPubMed
34.
Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16:389–402.CrossRefPubMed
35.
Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4:2–6.
36.
Mayeux PR, MacMillan-Crow LA. Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. PharmacolTher. 2012;134:139–55.
37.
Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019;200:1487–95.
38.
Weiss E, Paugam-Burtz C, Jaber S. Shock etiologies and fluid management in liver failure. Semin Respir Crit Care Med. 2018;39:538–45.
39.
Volpicelli G, Lamorte A, Tullio M, et al. Point-of-care multiorgan ultrasonography for the evaluation of undifferentiated hypotension in the emergency department. Intensive Care Med. 2013;39:1290–8.CrossRefPubMed
40.
Shokoohi H, Boniface KS, Pourmand A, et al. Bedside ultrasound reduces diagnostic uncertainty and guides resuscitation in patients with undifferentiated hypotension. Crit Care Med. 2015;43:2562–9.CrossRefPubMed
41.
Sekiguchi H, Harada Y, Villarraga HR, et al. Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study. J Anesth. 2017;31:487–93.CrossRefPubMed
42.
Audimoolam VK, McPhail MJW, Willars C, et al. Predicting fluid responsiveness in acute liver failure. Anesth Analg. 2017;124:480–6.
43.
Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509–18.
44.
45.
Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979;2:1097–100.
46.
Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.
47.
Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int Suppl. 1999;72:S62–6.CrossRef
48.
Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial. 2009;22:169–72.
49.
Khan R, Koppe S. Modern management of acute liver failure. Gastroenterol Clin N Am. 2018;47:313–26.
50.
Slack AJ, Auzinger G, Willars C, et al. Ammonia clearance with hemofiltration in adults with liver disease. Liver Int. 2014;34:42–8.CrossRefPubMed
51.
Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.CrossRefPubMed
52.
Arora A, Kumar A, Prasad N, et al. INASL-ISN Joint Position Statements on management of patients with simultaneous liver and kidney disease. J Clin Exp Hepatol. 2021;11:354–86.
53.
Sivilotti ML, Juurlink DN, Garland JS, et al. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila). 2013;51:855–63.
54.
William B, Anna H, Amit G, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRef
55.
Raquel Olivo, Guarrera James V, Pyrsopoulos Nikalaos T. Liver transplantation for acute liver failure. Clin Liver Dis. 2018;56:409–17.
56.
Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation. 2006;81:195–201.CrossRefPubMed
57.
Leithead JA, Ferguson JW, Bates CM, Davidson JS, Simpson KJ, Hayes PC. Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction. Am J Transplant. 2011;11:1905–15.CrossRefPubMed
58.
Nadim MK, Annanthapanyasut W, Matsuoka L, et al. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver Transpl. 2014;20:756–64.CrossRefPubMed
59.
Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM. Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study. PLoS One. 2016;11:e0148782.
60.
Kim TS, Kim JM, Kwon CHD, Kim SJ, Joh JW, Lee SK. Prognostic factors predicting poor outcome in living-donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2017;49:1118–22.CrossRefPubMed
Metadata
Title
Acute kidney injury in acute liver failure: A narrative review
Authors
Brij Sharma
Anshul Bhateja
Rajesh Sharma
Ashish Chauhan
Vishal Bodh
Publication date
05-04-2024

Other articles of this Issue 2/2024

Indian Journal of Gastroenterology 2/2024 Go to the issue

Original Article

Respiratory tract viral infections associated sepsis in patients with underlying liver disease: Viral sepsis an entity to look forward!

Image

When liver reaches out to the heart!! Trans-diaphragmatic infiltration of hepatocellular carcinoma into the heart

Editorial

Prediction of mortality from hepatitis A virus-related acute liver failure in children—Do we have the perfect prognostic model?

Editorial

Albumin in hospitalized patients with complications of cirrhosis: Not a suit for all seasons

Original Article

Focused panel sequencing points to genetic predisposition in non-cirrhotic intrahepatic portal hypertension patients in India

Research letter

Difficult transplant decisions in acute liver failure —Benefit versus futility, where to draw a line
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits